Clinical trial
Low-Dose Leptin and the Formerly-Obese
NCT00073242 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Unknown status
Key facts
| NCT number | NCT00073242 |
|---|---|
| Title | Low-Dose Leptin and the Formerly-Obese |
| Official title | Effects of Low-Dose Leptin on the Metabolic/Behavioral Phenotypes of the Formerly-Obese |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Behavioral, Drug |
| Interventions | Leptin, Dietary modification, T3 repletion |
| Enrollment | 25 |
| Start date | Jul 1, 2000 |
| Primary completion | Jul 1, 2015 |
| Completion | Jul 1, 2015 |
| First posted | Nov 19, 2003 |
| Last update posted | Jun 4, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: